Priority 18 from the Mesothelioma PSP
| UNCERTAINTY: Is giving a course of radiotherapy to mesothelioma patients (especially new techniques such as Intensity Modulated Radiotherapy) before or after chemotherapy beneficial? (JLA PSP Priority 18) | |
|---|---|
| Overall ranking | 18 |
| JLA question ID | 0025/18 |
| Explanatory note | Not available for this PSP |
| Evidence | No systematic reviews or studies identified |
| Health Research Classification System category | Cancer |
| Extra information provided by this PSP | |
|---|---|
| Original uncertainty examples | The radiotherapy on his lung tumour relieved the pressure and pain for a short time ~ The only treatment undertaken was radiotherapy followed by chemotherapy which really did not seem to benefit the patient who had terrible side effects and the chemo had to be stopped ~ Chemo-radiotherapy I believe makes quality of life for patients after treatment poor. |
| Comparison | Drug |
| Submitted by | Bereaved x 2 ~ Health Professional |
| Outcomes to be measured | Quality of life |
| PSP information | |
|---|---|
| PSP unique ID | 0025 |
| PSP name | Mesothelioma |
| Total number of uncertainties identified by this PSP. | 53 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website) |
| Date of priority setting workshop | 16 December 2014 |